Click here for Filipino language

The Glycoproteomics

InterVenn is developing a first-in-class mass spec-based glycoproteomic clinical diagnostic test for ovarian cancer.

Currently undergoing clinical validation in a global, multi-center clinical trial, this proprietary test will enable clinicians to distinguish benign from malignant masses in women presenting with adnexal (pelvic) masses, through a simple blood test.


Be one of the woman giving voice to Ovarian Cancer.

"Participating in the VOCAL study will also support future research. Future research on these specimens and health information can help us learn more about cancers and other diseases, why they develop, and to improve diagnosis and/or treatment."

Frequently Asked Questions

1. What is the Purpose of the VOCAL Study?

The purpose of this study is to evaluate the clinical performance of the InterVenn Ovarian CAncer Liquid Biopsy (VOCAL) test by collecting and storing biological samples (blood) and characterizing protein biomarkers in serum of cancer versus non-cancer patients.

2. How Do I Know if I Qualify for the Study?

The VOCAL study is for adult women who present with a known adnexal (pelvic) mass discovered by an imaging test, such as an ultrasound or CT scan.

A total of 1,200 subjects from various parts of the world will be participating in this study.

For more information, please email ovarian@venn.bio or visit clinicaltrials.gov

3. What Are The Risks of Participation in this Research Study?

The risks to participation are very small. Participation in the VOCAL study involves a simple blood draw prior to any surgery and the collection of your clinical data.

For more information, please email ovarian@venn.bio or visit clinicaltrials.gov

4. What Are The Benefits of Participation in this Research Study?

There is no direct benefit to the participants of this research study. The benefit goes to research and the development of a diagnostic profile for ovarian cancer.

5. What Else Do I Need to Know?

The study doctor and research team will review all of the details of the clinical study in further detail. You will also be given an informed consent document, which will include a complete overview of the study.

6. Is There A Research Site Close to Me?

The study is being conducted in multiple locations throughout the United States, Australia, the Philippines and Malaysia.

To locate contact information for a clinical site, go to ovarian@venn.bio or visit clinicaltrials.gov or contact ovarian@venn.bio

If local to the Philippines, please visit Health Research